| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 147.06B | 142.91B | 132.58B | 123.70B | 156.57B | 333.60B |
| Gross Profit | 69.23B | 66.31B | 60.54B | 55.35B | 66.27B | 62.16B |
| EBITDA | 48.80B | 70.71B | -1.46B | 32.41B | 27.55B | 20.73B |
| Net Income | 20.66B | 43.32B | -27.81B | 20.89B | 15.64B | 9.35B |
Balance Sheet | ||||||
| Total Assets | 296.73B | 303.18B | 290.17B | 322.69B | 301.60B | 236.26B |
| Cash, Cash Equivalents and Short-Term Investments | 62.37B | 66.23B | 49.48B | 51.69B | 50.20B | 50.20B |
| Total Debt | 82.26B | 87.93B | 110.63B | 103.86B | 149.09B | 161.68B |
| Total Liabilities | 216.61B | 232.66B | 249.81B | 252.87B | 246.45B | 249.19B |
| Stockholders Equity | 78.12B | 68.20B | 38.62B | 68.61B | 54.48B | 38.51B |
Cash Flow | ||||||
| Free Cash Flow | 21.18B | 21.88B | 16.34B | 3.38B | 14.80B | 21.45B |
| Operating Cash Flow | 23.96B | 25.95B | 18.67B | 5.39B | 17.99B | 24.77B |
| Investing Cash Flow | -8.01B | 30.00B | -5.80B | 10.02B | -4.95B | -4.28B |
| Financing Cash Flow | -16.76B | -41.28B | -7.79B | -16.97B | -19.07B | -7.48B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | ¥16.59B | 15.74 | ― | 1.49% | 1.23% | 0.12% | |
74 Outperform | ¥88.51B | 14.97 | 11.16% | 3.41% | 10.87% | -5.96% | |
69 Neutral | ¥299.89B | 14.55 | 30.73% | 2.20% | 4.52% | ― | |
66 Neutral | ¥70.85B | 12.14 | ― | 2.18% | 12.03% | 30.12% | |
65 Neutral | ¥35.08B | 18.51 | ― | 2.59% | 4.02% | 18.12% | |
65 Neutral | ¥20.75B | 30.65 | ― | 1.13% | 3.37% | 9.00% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% |